COVID-19 Impact on Global Antinuclear Antibody Testing Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: C22C4B5460E0EN
QYResearch

Abstracts

This report focuses on the global Antinuclear Antibody Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antinuclear Antibody Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Alere, Inc.
• Abbott Laboratories
• Antibodies, Inc.
• Bio-Rad Laboratories, Inc.
• Biocom Biotech
• Erba Diagnostics, Inc.
• Euroimmun AG
• HUMAN Diagnostics, Inc.
• Immuno Concepts, Inc.
• Inova Diagnostics, Inc.
• Thermo Fisher Scientific, Inc.
• Trinity Biotech Plc
• Zeus Scientific, Inc.

Market segment by Type, the product can be split into

• Reagents & Assay Kits
• Software & Services
• Systems

Market segment by Application, split into

• Rheumatoid Arthritis
• Scleroderma
• Systemic Lupus Erythematosus
• Sj?gren’s Syndrome
• Other Diseases

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Antinuclear Antibody Testing status, future forecast, growth opportunity, key market and key players.
• To present the Antinuclear Antibody Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antinuclear Antibody Testing are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antinuclear Antibody Testing Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antinuclear Antibody Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Reagents & Assay Kits
  1.4.3 Software & Services
  1.4.4 Systems
1.5 Market by Application
  1.5.1 Global Antinuclear Antibody Testing Market Share by Application: 2020 VS 2026
  1.5.2 Rheumatoid Arthritis
  1.5.3 Scleroderma
  1.5.4 Systemic Lupus Erythematosus
  1.5.5 Sj?gren’s Syndrome
  1.5.6 Other Diseases
1.6 Coronavirus Disease 2019 (Covid-19): Antinuclear Antibody Testing Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antinuclear Antibody Testing Industry
    1.6.1.1 Antinuclear Antibody Testing Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antinuclear Antibody Testing Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antinuclear Antibody Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antinuclear Antibody Testing Market Perspective (2015-2026)
2.2 Antinuclear Antibody Testing Growth Trends by Regions
  2.2.1 Antinuclear Antibody Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antinuclear Antibody Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Antinuclear Antibody Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antinuclear Antibody Testing Market Growth Strategy
  2.3.6 Primary Interviews with Key Antinuclear Antibody Testing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antinuclear Antibody Testing Players by Market Size
  3.1.1 Global Top Antinuclear Antibody Testing Players by Revenue (2015-2020)
  3.1.2 Global Antinuclear Antibody Testing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antinuclear Antibody Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antinuclear Antibody Testing Market Concentration Ratio
  3.2.1 Global Antinuclear Antibody Testing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antinuclear Antibody Testing Revenue in 2019
3.3 Antinuclear Antibody Testing Key Players Head office and Area Served
3.4 Key Players Antinuclear Antibody Testing Product Solution and Service
3.5 Date of Enter into Antinuclear Antibody Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antinuclear Antibody Testing Historic Market Size by Type (2015-2020)
4.2 Global Antinuclear Antibody Testing Forecasted Market Size by Type (2021-2026)

5 ANTINUCLEAR ANTIBODY TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antinuclear Antibody Testing Market Size by Application (2015-2020)
5.2 Global Antinuclear Antibody Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antinuclear Antibody Testing Market Size (2015-2020)
6.2 Antinuclear Antibody Testing Key Players in North America (2019-2020)
6.3 North America Antinuclear Antibody Testing Market Size by Type (2015-2020)
6.4 North America Antinuclear Antibody Testing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antinuclear Antibody Testing Market Size (2015-2020)
7.2 Antinuclear Antibody Testing Key Players in Europe (2019-2020)
7.3 Europe Antinuclear Antibody Testing Market Size by Type (2015-2020)
7.4 Europe Antinuclear Antibody Testing Market Size by Application (2015-2020)

8 CHINA

8.1 China Antinuclear Antibody Testing Market Size (2015-2020)
8.2 Antinuclear Antibody Testing Key Players in China (2019-2020)
8.3 China Antinuclear Antibody Testing Market Size by Type (2015-2020)
8.4 China Antinuclear Antibody Testing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antinuclear Antibody Testing Market Size (2015-2020)
9.2 Antinuclear Antibody Testing Key Players in Japan (2019-2020)
9.3 Japan Antinuclear Antibody Testing Market Size by Type (2015-2020)
9.4 Japan Antinuclear Antibody Testing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antinuclear Antibody Testing Market Size (2015-2020)
10.2 Antinuclear Antibody Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antinuclear Antibody Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Antinuclear Antibody Testing Market Size by Application (2015-2020)

11 INDIA

11.1 India Antinuclear Antibody Testing Market Size (2015-2020)
11.2 Antinuclear Antibody Testing Key Players in India (2019-2020)
11.3 India Antinuclear Antibody Testing Market Size by Type (2015-2020)
11.4 India Antinuclear Antibody Testing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antinuclear Antibody Testing Market Size (2015-2020)
12.2 Antinuclear Antibody Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Antinuclear Antibody Testing Market Size by Type (2015-2020)
12.4 Central & South America Antinuclear Antibody Testing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Alere, Inc.
  13.1.1 Alere, Inc. Company Details
  13.1.2 Alere, Inc. Business Overview and Its Total Revenue
  13.1.3 Alere, Inc. Antinuclear Antibody Testing Introduction
  13.1.4 Alere, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020))
  13.1.5 Alere, Inc. Recent Development
13.2 Abbott Laboratories
  13.2.1 Abbott Laboratories Company Details
  13.2.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.2.3 Abbott Laboratories Antinuclear Antibody Testing Introduction
  13.2.4 Abbott Laboratories Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.2.5 Abbott Laboratories Recent Development
13.3 Antibodies, Inc.
  13.3.1 Antibodies, Inc. Company Details
  13.3.2 Antibodies, Inc. Business Overview and Its Total Revenue
  13.3.3 Antibodies, Inc. Antinuclear Antibody Testing Introduction
  13.3.4 Antibodies, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.3.5 Antibodies, Inc. Recent Development
13.4 Bio-Rad Laboratories, Inc.
  13.4.1 Bio-Rad Laboratories, Inc. Company Details
  13.4.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
  13.4.3 Bio-Rad Laboratories, Inc. Antinuclear Antibody Testing Introduction
  13.4.4 Bio-Rad Laboratories, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.4.5 Bio-Rad Laboratories, Inc. Recent Development
13.5 Biocom Biotech
  13.5.1 Biocom Biotech Company Details
  13.5.2 Biocom Biotech Business Overview and Its Total Revenue
  13.5.3 Biocom Biotech Antinuclear Antibody Testing Introduction
  13.5.4 Biocom Biotech Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.5.5 Biocom Biotech Recent Development
13.6 Erba Diagnostics, Inc.
  13.6.1 Erba Diagnostics, Inc. Company Details
  13.6.2 Erba Diagnostics, Inc. Business Overview and Its Total Revenue
  13.6.3 Erba Diagnostics, Inc. Antinuclear Antibody Testing Introduction
  13.6.4 Erba Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.6.5 Erba Diagnostics, Inc. Recent Development
13.7 Euroimmun AG
  13.7.1 Euroimmun AG Company Details
  13.7.2 Euroimmun AG Business Overview and Its Total Revenue
  13.7.3 Euroimmun AG Antinuclear Antibody Testing Introduction
  13.7.4 Euroimmun AG Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.7.5 Euroimmun AG Recent Development
13.8 HUMAN Diagnostics, Inc.
  13.8.1 HUMAN Diagnostics, Inc. Company Details
  13.8.2 HUMAN Diagnostics, Inc. Business Overview and Its Total Revenue
  13.8.3 HUMAN Diagnostics, Inc. Antinuclear Antibody Testing Introduction
  13.8.4 HUMAN Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.8.5 HUMAN Diagnostics, Inc. Recent Development
13.9 Immuno Concepts, Inc.
  13.9.1 Immuno Concepts, Inc. Company Details
  13.9.2 Immuno Concepts, Inc. Business Overview and Its Total Revenue
  13.9.3 Immuno Concepts, Inc. Antinuclear Antibody Testing Introduction
  13.9.4 Immuno Concepts, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.9.5 Immuno Concepts, Inc. Recent Development
13.10 Inova Diagnostics, Inc.
  13.10.1 Inova Diagnostics, Inc. Company Details
  13.10.2 Inova Diagnostics, Inc. Business Overview and Its Total Revenue
  13.10.3 Inova Diagnostics, Inc. Antinuclear Antibody Testing Introduction
  13.10.4 Inova Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  13.10.5 Inova Diagnostics, Inc. Recent Development
13.11 Thermo Fisher Scientific, Inc.
  10.11.1 Thermo Fisher Scientific, Inc. Company Details
  10.11.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
  10.11.3 Thermo Fisher Scientific, Inc. Antinuclear Antibody Testing Introduction
  10.11.4 Thermo Fisher Scientific, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  10.11.5 Thermo Fisher Scientific, Inc. Recent Development
13.12 Trinity Biotech Plc
  10.12.1 Trinity Biotech Plc Company Details
  10.12.2 Trinity Biotech Plc Business Overview and Its Total Revenue
  10.12.3 Trinity Biotech Plc Antinuclear Antibody Testing Introduction
  10.12.4 Trinity Biotech Plc Revenue in Antinuclear Antibody Testing Business (2015-2020)
  10.12.5 Trinity Biotech Plc Recent Development
13.13 Zeus Scientific, Inc.
  10.13.1 Zeus Scientific, Inc. Company Details
  10.13.2 Zeus Scientific, Inc. Business Overview and Its Total Revenue
  10.13.3 Zeus Scientific, Inc. Antinuclear Antibody Testing Introduction
  10.13.4 Zeus Scientific, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020)
  10.13.5 Zeus Scientific, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antinuclear Antibody Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Antinuclear Antibody Testing Revenue
Table 3. Ranking of Global Top Antinuclear Antibody Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antinuclear Antibody Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents & Assay Kits
Table 6. Key Players of Software & Services
Table 7. Key Players of Systems
Table 8. COVID-19 Impact Global Market: (Four Antinuclear Antibody Testing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Antinuclear Antibody Testing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Antinuclear Antibody Testing Players to Combat Covid-19 Impact
Table 13. Global Antinuclear Antibody Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Antinuclear Antibody Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Antinuclear Antibody Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Antinuclear Antibody Testing Market Share by Regions (2015-2020)
Table 17. Global Antinuclear Antibody Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Antinuclear Antibody Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Antinuclear Antibody Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Antinuclear Antibody Testing Players
Table 24. Global Antinuclear Antibody Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Antinuclear Antibody Testing Market Share by Players (2015-2020)
Table 26. Global Top Antinuclear Antibody Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody Testing as of 2019)
Table 27. Global Antinuclear Antibody Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Antinuclear Antibody Testing Product Solution and Service
Table 30. Date of Enter into Antinuclear Antibody Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Antinuclear Antibody Testing Market Size Share by Type (2015-2020)
Table 34. Global Antinuclear Antibody Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Antinuclear Antibody Testing Market Size Share by Application (2015-2020)
Table 36. Global Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Antinuclear Antibody Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 40. North America Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 42. North America Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 46. Europe Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 48. Europe Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 50. China Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 52. China Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 54. China Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 58. Japan Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 60. Japan Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 64. Southeast Asia Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 68. India Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 70. India Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 72. India Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Antinuclear Antibody Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Antinuclear Antibody Testing Market Share (2019-2020)
Table 76. Central & South America Antinuclear Antibody Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Antinuclear Antibody Testing Market Share by Type (2015-2020)
Table 78. Central & South America Antinuclear Antibody Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Antinuclear Antibody Testing Market Share by Application (2015-2020)
Table 80. Alere, Inc. Company Details
Table 81. Alere, Inc. Business Overview
Table 82. Alere, Inc. Product
Table 83. Alere, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 84. Alere, Inc. Recent Development
Table 85. Abbott Laboratories Company Details
Table 86. Abbott Laboratories Business Overview
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 89. Abbott Laboratories Recent Development
Table 90. Antibodies, Inc. Company Details
Table 91. Antibodies, Inc. Business Overview
Table 92. Antibodies, Inc. Product
Table 93. Antibodies, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 94. Antibodies, Inc. Recent Development
Table 95. Bio-Rad Laboratories, Inc. Company Details
Table 96. Bio-Rad Laboratories, Inc. Business Overview
Table 97. Bio-Rad Laboratories, Inc. Product
Table 98. Bio-Rad Laboratories, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 99. Bio-Rad Laboratories, Inc. Recent Development
Table 100. Biocom Biotech Company Details
Table 101. Biocom Biotech Business Overview
Table 102. Biocom Biotech Product
Table 103. Biocom Biotech Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 104. Biocom Biotech Recent Development
Table 105. Erba Diagnostics, Inc. Company Details
Table 106. Erba Diagnostics, Inc. Business Overview
Table 107. Erba Diagnostics, Inc. Product
Table 108. Erba Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 109. Erba Diagnostics, Inc. Recent Development
Table 110. Euroimmun AG Company Details
Table 111. Euroimmun AG Business Overview
Table 112. Euroimmun AG Product
Table 113. Euroimmun AG Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 114. Euroimmun AG Recent Development
Table 115. HUMAN Diagnostics, Inc. Business Overview
Table 116. HUMAN Diagnostics, Inc. Product
Table 117. HUMAN Diagnostics, Inc. Company Details
Table 118. HUMAN Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 119. HUMAN Diagnostics, Inc. Recent Development
Table 120. Immuno Concepts, Inc. Company Details
Table 121. Immuno Concepts, Inc. Business Overview
Table 122. Immuno Concepts, Inc. Product
Table 123. Immuno Concepts, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 124. Immuno Concepts, Inc. Recent Development
Table 125. Inova Diagnostics, Inc. Company Details
Table 126. Inova Diagnostics, Inc. Business Overview
Table 127. Inova Diagnostics, Inc. Product
Table 128. Inova Diagnostics, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 129. Inova Diagnostics, Inc. Recent Development
Table 130. Thermo Fisher Scientific, Inc. Company Details
Table 131. Thermo Fisher Scientific, Inc. Business Overview
Table 132. Thermo Fisher Scientific, Inc. Product
Table 133. Thermo Fisher Scientific, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 134. Thermo Fisher Scientific, Inc. Recent Development
Table 135. Trinity Biotech Plc Company Details
Table 136. Trinity Biotech Plc Business Overview
Table 137. Trinity Biotech Plc Product
Table 138. Trinity Biotech Plc Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 139. Trinity Biotech Plc Recent Development
Table 140. Zeus Scientific, Inc. Company Details
Table 141. Zeus Scientific, Inc. Business Overview
Table 142. Zeus Scientific, Inc. Product
Table 143. Zeus Scientific, Inc. Revenue in Antinuclear Antibody Testing Business (2015-2020) (Million US$)
Table 144. Zeus Scientific, Inc. Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antinuclear Antibody Testing Market Share by Type: 2020 VS 2026
Figure 2. Reagents & Assay Kits Features
Figure 3. Software & Services Features
Figure 4. Systems Features
Figure 5. Global Antinuclear Antibody Testing Market Share by Application: 2020 VS 2026
Figure 6. Rheumatoid Arthritis Case Studies
Figure 7. Scleroderma Case Studies
Figure 8. Systemic Lupus Erythematosus Case Studies
Figure 9. Sj?gren’s Syndrome Case Studies
Figure 10. Other Diseases Case Studies
Figure 11. Antinuclear Antibody Testing Report Years Considered
Figure 12. Global Antinuclear Antibody Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Antinuclear Antibody Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Antinuclear Antibody Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Antinuclear Antibody Testing Market Share by Players in 2019
Figure 17. Global Top Antinuclear Antibody Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antinuclear Antibody Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Antinuclear Antibody Testing Revenue in 2019
Figure 19. North America Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Antinuclear Antibody Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Alere, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Alere, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 28. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Laboratories Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 30. Antibodies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Antibodies, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 32. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 34. Biocom Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Biocom Biotech Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 36. Erba Diagnostics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Erba Diagnostics, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 38. Euroimmun AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Euroimmun AG Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 40. HUMAN Diagnostics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. HUMAN Diagnostics, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 42. Immuno Concepts, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Immuno Concepts, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 44. Inova Diagnostics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Inova Diagnostics, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 46. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 48. Trinity Biotech Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Trinity Biotech Plc Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 50. Zeus Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zeus Scientific, Inc. Revenue Growth Rate in Antinuclear Antibody Testing Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed